Treatment Strategies for HIV‐Infected Patients with Tuberculosis: Ongoing and Planned Clinical Trials
Authors:
- François‐Xavier BlancFBFrançois‐Xavier Blanc
- Anne E. GoldfeldAGAnne E. Goldfeld
Open Access
- 1 July 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s1) , S46-S51
Abstract
Currently, there are limited data to guide the management of highly active antiretroviral therapy (HAART) for human immunodeficiency virus type 1 (HIKeywords
This publication has 13 references indexed in Scilit:
- Complications of Antiretroviral Therapy in Patients with Tuberculosis: Drug Interactions, Toxicity, and Immune Reconstitution Inflammatory SyndromeThe Journal of Infectious Diseases, 2007
- Treatment for Adult HIV InfectionJAMA, 2006
- Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settingsThe Lancet, 2006
- Drug–drug interactions and tolerance in combining antituberculosis and antiretroviral therapyExpert Opinion on Drug Safety, 2005
- Update on the Treatment of Tuberculosis and Latent Tuberculosis InfectionJAMA, 2005
- Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretroviralsThe Lancet Infectious Diseases, 2005
- Clinical Trial RegistrationJAMA, 2004
- A Community-Based Tuberculosis Program in CambodiaJAMA, 2004
- Clinical Management of Tuberculosis in the Context of HIV InfectionAnnual Review of Medicine, 2004
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003